UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003171
Receipt number R000003845
Scientific Title Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.
Date of disclosure of the study information 2010/03/01
Last modified on 2017/08/18 14:10:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.

Acronym

PEACH trial

Scientific Title

Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.

Scientific Title:Acronym

PEACH trial

Region

Japan


Condition

Condition

Patient with dyslipidemia and with coronary artery calcification.(Agatston score 1-999)
(Patient of primary prevention of coronary heart disease)

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of Pitavastatin on coronary calcification score. (compariosn with highdose treatment and combination with EPA)

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The effect of Pitavastatin on coronary calcification score. (compariosn with highdose treatment and combination with EPA)

Key secondary outcomes

1) The ratio of achivement of LDL-C level on Guidline.
2) Changes in TC, LDL-C, TG, HDL-C, adiponectin, fatty asid furaction, RLP-C, subfraction of HDL, hs-CRP, MCP-1, Oxdative LDL, Quantification of CD34, RBC, WBC, Hb, Ht, platelate, BNP, creatinin, BUN, uricacid, total bilirubin, AST, ALT, gamma-GTP, CK(CPK), LDH, serum Na, serum K, serum Cl, FBS, fasting insulin
3)The ratio of MACCE
4)The ratio of adverse effect
5)The relation between clinical parameter and coronary calcification score,
relation between clinical parameter and ratio of MACCE.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Pitavastatin 2mg

Interventions/Control_2

Pitavastatin 4mg

Interventions/Control_3

Pitavastatin 2mg and EPA 1800mg

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Dyslipidemia patient defined by guidline, or already treated by anti-dyslipidemia drugs.
2)Patient without recived PCI and CABG
3)Patient coronary CT within two months., And detected coronary artery calcification(Agatston score 1-999).
4)Over 20 years old.

Key exclusion criteria

1)Patient with PCI or CABG.
2)Patient can't obtained clear CT image.
3Patient without coronary artery calcification(Agatsuton score=0)
4)Patient with heaviry-calcification on coronary artery (Agatston score >=1000)
5)Patient who are favorite to treat with anti-dyslipidemia drugs other than statin.
6)Famirial hypercholesterolemia.
7)Patient corresponded contraindication of Pitavastatin.
8)Patient considered to be improper to this trial by attending doctor.

Target sample size

240


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Ito

Organization

Okayama Univesity Graduate School of Medicine,Dentistry and Pharmaceutical Sciences

Division name

Department of Cardiovascular Medicine

Zip code


Address

2-5-1, Shikata-cho, Kita-ku, Okayama

TEL

086-235-7351

Email

itomd@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kunihisa Kohno

Organization

Okayama Univesity hospital

Division name

Department of Cardiovascular Medicine

Zip code


Address

2-5-1, Shikata-cho, Kita-ku, Okayama

TEL

086-235-7351

Homepage URL


Email

kunihisakohno@msn.com


Sponsor or person

Institute

Department of Cardiovascular Medicine,
Okayama Univesity Graduate School of Medicine,Dentistry and Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

Japan Heart Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

赤穂中央病院(兵庫県)、岩国医療センター(山口県)、愛媛県立中央病院(愛媛県)、岡山医療センター(岡山県)、岡山済生会総合病院(岡山県)、岡山市民病院(岡山県)、岡山赤十字病院(岡山県)、岡山大学病院(岡山県)、岡山労災病院(岡山県)、尾道市民病院(広島県)、香川県立中央病院(香川県)、笠岡第一病院(香川県)、済生会今治病院(岡山県)、済生会松山病院(愛媛県)、住友別子病院(愛媛県)、高松赤十字病院(香川県)、中国中央病院(広島県)、津山中央病院(岡山県)、鳥取市立病院(鳥取県)、久松内科循環器科(岡山県)、姫路赤十字病院(兵庫県)、福山医療センター(広島県)、福山市民病院(広島県)、福山循環器病院(広島県)、松山市民病院(愛媛県)、三豊総合病院(香川県)、屋島総合病院(香川県)


Other administrative information

Date of disclosure of the study information

2010 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 12 Month 15 Day

Date of IRB


Anticipated trial start date

2010 Year 05 Month 01 Day

Last follow-up date

2012 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 02 Month 12 Day

Last modified on

2017 Year 08 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003845


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name